Literature DB >> 29878335

Recent advances in targeting ion channels to treat chronic pain.

Edward B Stevens1, Gary J Stephens2.   

Abstract

LINKED ARTICLES: This article is part of a themed section on Recent Advances in Targeting Ion Channels to Treat Chronic Pain. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v175.12/issuetoc.
© 2018 The British Pharmacological Society.

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29878335      PMCID： PMC5980455          DOI： 10.1111/bph.14215

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN： 0007-1188            Impact factor:   8.739


  30 in total

1.  Unbiased classification of sensory neuron types by large-scale single-cell RNA sequencing.

Authors:  Dmitry Usoskin; Alessandro Furlan; Saiful Islam; Hind Abdo; Peter Lönnerberg; Daohua Lou; Jens Hjerling-Leffler; Jesper Haeggström; Olga Kharchenko; Peter V Kharchenko; Sten Linnarsson; Patrik Ernfors
Journal:  Nat Neurosci       Date:  2014-11-24       Impact factor: 24.884

Review 2.  Sodium channels and pain: from toxins to therapies.

Authors:  Fernanda C Cardoso; Richard J Lewis
Journal:  Br J Pharmacol       Date:  2017-09-02       Impact factor: 8.739

Review 3.  Using automated patch clamp electrophysiology platforms in pain-related ion channel research: insights from industry and academia.

Authors:  Damian C Bell; Mark L Dallas
Journal:  Br J Pharmacol       Date:  2017-07-18       Impact factor: 8.739

Review 4.  Recent advances in the development of T-type calcium channel blockers for pain intervention.

Authors:  Terrance P Snutch; Gerald W Zamponi
Journal:  Br J Pharmacol       Date:  2017-07-12       Impact factor: 8.739

5.  Inhibition of acid-sensing ion channels by diminazene and APETx2 evoke partial and highly variable antihyperalgesia in a rat model of inflammatory pain.

Authors:  Jia Yu Peppermint Lee; Natalie J Saez; Ben Cristofori-Armstrong; Raveendra Anangi; Glenn F King; Maree T Smith; Lachlan D Rash
Journal:  Br J Pharmacol       Date:  2018-01-03       Impact factor: 8.739

6.  Efficacy of the Nav1.7 blocker PF-05089771 in a randomised, placebo-controlled, double-blind clinical study in subjects with painful diabetic peripheral neuropathy.

Authors:  Aoibhinn McDonnell; Susie Collins; Zahid Ali; Laura Iavarone; Raulin Surujbally; Simon Kirby; Richard P Butt
Journal:  Pain       Date:  2018-08       Impact factor: 6.961

7.  Activity of novel lipid glycine transporter inhibitors on synaptic signalling in the dorsal horn of the spinal cord.

Authors:  Bryony L Winters; Tristan Rawling; Robert J Vandenberg; Macdonald J Christie; Rebecca F Bhola; Wendy L Imlach
Journal:  Br J Pharmacol       Date:  2018-04-14       Impact factor: 8.739

Review 8.  Evidence for spinal N-methyl-d-aspartate receptor involvement in prolonged chemical nociception in the rat.

Authors:  Jane E Haley; Anthony H Dickenson
Journal:  Brain Res       Date:  2016-02-15       Impact factor: 3.252

9.  Cyclic analogues of α-conotoxin Vc1.1 inhibit colonic nociceptors and provide analgesia in a mouse model of chronic abdominal pain.

Authors:  Joel Castro; Luke Grundy; Annemie Deiteren; Andrea M Harrington; Tracey O'Donnell; Jessica Maddern; Jessi Moore; Sonia Garcia-Caraballo; Grigori Y Rychkov; Rilei Yu; Quentin Kaas; David J Craik; David J Adams; Stuart M Brierley
Journal:  Br J Pharmacol       Date:  2018-02-13       Impact factor: 8.739

Review 10.  Fast synaptic inhibition in spinal sensory processing and pain control.

Authors:  Hanns Ulrich Zeilhofer; Hendrik Wildner; Gonzalo E Yévenes
Journal:  Physiol Rev       Date:  2012-01       Impact factor: 37.312
View more
  7 in total

1.  Getting a handle on CaV2.2 (N-type) voltage-gated Ca2+ channels.

Authors:  Jörg Striessnig
Journal:  Proc Natl Acad Sci U S A       Date:  2018-12-11       Impact factor: 11.205

2.  Systemic, Intrathecal, and Intracerebroventricular Antihyperalgesic Effects of the Calcium Channel Blocker CTK 01512-2 Toxin in Persistent Pain Models.

Authors:  Juliana Cavalli; Pollyana Mendonça de Assis; Elaine Cristina Dalazen Gonçalves; Larissa Daniele Bobermin; André Quincozes-Santos; Nádia Rezende Barbosa Raposo; Marcus Vinicius Gomez; Rafael Cypriano Dutra
Journal:  Mol Neurobiol       Date:  2022-05-16       Impact factor: 5.590

3.  Pharmacological Management of Adults with Chronic Non-Cancer Pain in General Practice.

Authors:  Cesare Bonezzi; Diego Fornasari; Claudio Cricelli; Alberto Magni; Giuseppe Ventriglia
Journal:  Pain Ther       Date:  2020-12-14

Review 4.  Neuropathic Pain in Multiple Sclerosis and Its Animal Models: Focus on Mechanisms, Knowledge Gaps and Future Directions.

Authors:  Ersilia Mirabelli; Stella Elkabes
Journal:  Front Neurol       Date:  2021-12-16       Impact factor: 4.003

Review 5.  Peripheral mechanisms of chronic pain.

Authors:  Qin Zheng; Xintong Dong; Dustin P Green; Xinzhong Dong
Journal:  Med Rev (Berl)       Date:  2022-07-07

6.  miR-155-5p in the spinal cord regulates hypersensitivity in a rat model of bone cancer pain.

Authors:  Qiuli He; Lei Liu; Yahui Wang; Chengfei Xu; Miao Xu; Jie Fu; Jianjun Zhu; Baoxia Zhao; Chaobo Ni; Ming Yao; Xuewu Lin; Huadong Ni
Journal:  Mol Pain       Date:  2022-04       Impact factor: 3.370

7.  Human Labor Pain Is Influenced by the Voltage-Gated Potassium Channel KV6.4 Subunit.

Authors:  Michael C Lee; Michael S Nahorski; James R F Hockley; Van B Lu; Gillian Ison; Luke A Pattison; Gerard Callejo; Kaitlin Stouffer; Emily Fletcher; Christopher Brown; Ichrak Drissi; Daniel Wheeler; Patrik Ernfors; David Menon; Frank Reimann; Ewan St John Smith; C Geoffrey Woods
Journal:  Cell Rep       Date:  2020-07-21       Impact factor: 9.423
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.